|
Volumn 340, Issue 6127, 2013, Pages 1559-1562
|
Diagnostic cancer genome sequencing and the contribution of germline variants
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATM PROTEIN;
DNA;
DNA DIRECTED DNA POLYMERASE DELTA;
DNA DIRECTED DNA POLYMERASE EPSILON;
PROTEIN P53;
CELL CYCLE PROTEIN;
DNA BINDING PROTEIN;
DNA DIRECTED DNA POLYMERASE ALPHA;
DNA DIRECTED DNA POLYMERASE GAMMA;
POLD1 PROTEIN, HUMAN;
POLE PROTEIN, HUMAN;
PROTEIN SERINE THREONINE KINASE;
TUMOR SUPPRESSOR PROTEIN;
CANCER;
COST-BENEFIT ANALYSIS;
GENOME;
RESEARCH WORK;
CANCER DIAGNOSIS;
CANCER SUSCEPTIBILITY;
COLON CANCER;
GENE MUTATION;
GENE SEQUENCE;
HUMAN;
PENETRANCE;
PREDICTION;
PRIORITY JOURNAL;
REVIEW;
WHOLE GENOME SEQUENCING;
GENETIC PREDISPOSITION;
GENETICS;
HUMAN GENOME;
METHODOLOGY;
MUTATION;
NEOPLASM;
NUCLEOTIDE SEQUENCE;
CELL CYCLE PROTEINS;
DNA MUTATIONAL ANALYSIS;
DNA POLYMERASE II;
DNA POLYMERASE III;
DNA-BINDING PROTEINS;
GENETIC PREDISPOSITION TO DISEASE;
GENOME, HUMAN;
GERM-LINE MUTATION;
HUMANS;
NEOPLASMS;
PENETRANCE;
PROTEIN-SERINE-THREONINE KINASES;
TUMOR SUPPRESSOR PROTEIN P53;
TUMOR SUPPRESSOR PROTEINS;
MLCS;
MLOWN;
|
EID: 84875552595
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1233899 Document Type: Review |
Times cited : (52)
|
References (50)
|